Home » Prices » NASDAQ:CNCE

Concert Pharmaceuticals, Inc. stock price

Today's NASDAQ:CNCE chart, history & news

Price:
11.37 USD
Change:
+0.35 (3.18%)
Key Stats
Price open 11
Previous close 11.02
Market cap 348.48M
Volume 78.32K
Day high 11.73
Day low 10.62
Year high 13.09
Year low 5.98
Year to date change 26.76%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA.

Company information

Company name
Concert Pharmaceuticals Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
70
CEO
Roger D. Tung
Address
65 Hayden Avenue, Lexington, MA, 02421
Country
United States
Contact information
1.781.860.0045
Website
http://www.concertpharma.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.